Quality of life in patients with multiple sclerosis: The impact of fatigue and depression

Journal of the Neurological Sciences

Volumn 205, Issue 1, 2002, Pages 51-58

  Janardhan, Vallabh ^a   Bakshi, Rohit ^b,c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Kaleida Health ^*  (United States)

Author keywords

Depression; Disability; Expanded disability status scale; Fatigue; Fatigue severity scale; Multiple sclerosis; Quality of life

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; EMOTIONAL DISORDER; FATIGUE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL HEALTH; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RELAPSE; REMISSION; SCORING SYSTEM; SEXUAL DYSFUNCTION;

ADOLESCENT; ADULT; DEPRESSION; DISABILITY EVALUATION; FATIGUE; FEMALE; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0037116191     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00312-X     Document Type: Article

References (46)

1. Vickrey B.G., Hays R.D., Harooni R., Myers L.W., Ellison G.W. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 4:1995;187-206.
2. Janardhan V., Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch. Neurol. 57:2000;1485-1491.
3. Henriksson F., Fredrikson S., Masterman T., Jonsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur. J. Neurol. 8:2001;27-35.
4. Burden of illness of multiple sclerosis: Part II. Quality of life. The Canadian Burden of Illness Study Group. Can J Neurol Sci 1998;25:31-8.
5. Nortvedt M.W., Riise T., Myhr K.M., Nyland H.I. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 53:1999;1098-1103.
6. Pfennings L., Cohen L., Ader H.et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J. Neurol. 246:1999;587-591.
7. Nortvedt M.W., Riise T., Myhr K.M., Nyland H.I. Quality of life as a predictor for change in disability in MS. Neurology. 55:2000;51-54.
8. Modrego P.J., Pina M.A., Simon A., Azuara M.C. The interrelations between disability and quality of life in patients with multiple sclerosis in the area of Bajo Aragon, Spain: a geographically based survey. Neurorehabil. Neural Repair. 15:2001;69-73.
9. O'Connor P., Lee L., Ng P.T., Narayana P., Wolinsky J.S. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology. 57:2001;889-891.
10. Krupp L.B., LaRocca N.G., Muir-Nash J., Steinberg A.D. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 46:1989;1121-1123.
11. Fisk J.D., Pontefract A., Ritvo P.G., Archibald C.J., Murray T.J. The impact of fatigue on patients with multiple sclerosis. Can. J. Neurol. Sci. 21:1994;9-14.
12. Colosima C., Millefiorini E., Grasso M.G.et al. Fatigue in MS is associated with specific clinical features. Acta Neurol. Scand. 92:1995;353-355.
13. Bergamaschi R., Romani A., Versino M., Poli R., Cosi V. Clinical aspects of fatigue in multiple sclerosis. Funct. Neurology. 12:1997;247-251.
14. Bakshi R., Shaikh Z.A., Miletich R.S.et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult. Scler. 6:2000;181-185.
15. Minden S.L., Schiffer R.B. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch. Neurol. 47:1990;98-104.
16. Krupp L.B., Coyle P.K., Doscher C.et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology. 45:1995;1956-1961.
17. Anderson I.M. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J. Affect. Disord. 58:2000;19-36.
18. Petajan J.H., Gappmaier E., White A.T., Spencer M.K., Mino L., Hicks R.W. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann. Neurol. 39:1996;432-441.
19. Lengdobler H., Kiessling W.R. Group music therapy in multiple sclerosis: initial report of experience. Psychother. Psychosom. Med. Psychol. 39:1989;369-373.
20. Sandyk R. Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis. Int. J. Neurosci. 84:1996;177-186.
21. Krupp L.B., Pollina D.A. Mechanisms and management of fatigue in progressive neurological disorders. Curr. Opin. Neurol. 9:1996;456-460.
22. Poser C.M., Paty D.W., Scheinberg L.et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
23. Bakshi R., Miletich R.S., Henschel K.et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology. 53:1999;1151-1153.
24. Mohr D.C., Goodkin D.E., Likosky W., Gatto N., Baumann K.A., Rudick R.A. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch. Neurol. 54:1997;531-533.
25. Diagnostic and statistical manual of mental disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC.
26. Vickrey B.G., Hays R.D., Genovese B.J., Myers L.W., Ellison G.W. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J. Clin. Epidemiol. 50:1997;557-569.
27. Solari A., Filippini G., Mendozzi L.et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J. Neurol. Neurosurg. Psychiatry. 67:1999;158-162.
28. Vernay D., Gerbaud L., Biolay S.et al. Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59). Rev. Neurol. (Paris). 156:2000;247-263.
29. Ware J.E., Snow K.K., Kosinsky M., Gandek B. SF-36 health survey manual and interpretation guide. 1993;New England Medical Center, Health Institute, Boston, MA.
30. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 46:1996;907-911.
31. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
32. Krupp L.B., Alvarez L.A., LaRocca N.G., Scheinberg L.C. Fatigue in multiple sclerosis. Arch. Neurol. 45:1988;435-437.
33. Roelcke U., Kappos L., Lechner-Scott J.et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology. 48:1997;1566-1571.
34. Reynolds W.M., Kobak K.A. Hamilton depression inventory. A self-report version of the Hamilton depression rating scale (HDRS). 1995;Psychological Assessment Services, Odessa.
35. Thompson A.J. Measuring handicap in multiple sclerosis. Mult. Scler. 5:1999;260-262.
36. Rothwell P.M. Quality of life in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 65:1998;433.
37. Truyen L., van Waesberghe J.H.T.M., van Walderveen M.A.A.et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 47:1996;1469-1476.
38. Bakshi R., Benedict R.H., Bermel R.A., Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J. Neuroimaging. 11:2001;129-136.
39. Wang J.L., Reimer M.A., Metz L.M., Patten S.B. Major depression and quality of life in individuals with multiple sclerosis. Int. J. Psychiatry Med. 30:2000;309-317.
40. Bakshi R., Czarnecki D., Shaikh Z.A.et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport. 11:2000;1153-1158.
41. Zorzon M., de Masi R., Nasuelli D.et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J. Neurol. 248:2001;416-421.
42. Bakshi R., Miletich R.S., Kinkel P.R., Emmet M.L., Kinkel W.R. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J. Neuroimaging. 8:1998;228-234.
43. Bakshi R., Miletich R.S., Czarnecki D., Kinkel P.R., Emmet M.L., Kinkel W.R. Depression in multiple sclerosis is associated with widespread cerebral gray matter and white matter glucose hypometabolism: a prospective fluorodeoxyglucose positron emission tomography study (abstract). Neurology. 50:1998;A323.
44. Cutajar R., Ferriani E., Scandellari C.et al. Cognitive function and quality of life in multiple sclerosis patients. J. Neurovirology. 6:2000;S186-S190.
45. Benedict R.H.B., Priore R.L., Miller C., Munschauser F., Jacobs L. Personality disorder in MS correlates with cognitive impairment. J. Neuropsychiatr. Clin. Neurosci. 13:2001;70-76.
46. Nortvedt M.W., Riise T., Myhr K.M., Landtblom A.M., Bakke A., Nyland H.I. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult. Scler. 7:2001;231-235.